WaveMan
WaveMan · Company
MD · Pediatrix Medical Group, Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

MD Pediatrix Medical (MD) Insider Trading, Ownership & Congress Trades

Healthcare Services · Services-hospitals · CIK 0000893949
Quote by TradingView
Form 144 · 4
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
153
13F, latest reported quarter

What the filings say about MD

Insiders, 180 days
-$855.7K net sold
1 seller · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$1.5M
4 notices

Pediatrix Medical insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, Pediatrix Medical Group, Inc. insiders sold a net $855.7K of stock across 37 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.

Insider
Filed
Shares
Value
Since filing
Weis Shirley A
Director
SELL
2026-05-14 SECtraded 2026-05-13
36,028
$855.7K
+30.2%
Context
  • 2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on May 19, 2023.
  • No other insider sold within 30 days.
  • 153 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Weis Shirley A sold about $855.7K of MD on May 13, 2026, the largest insider sale at the company since 2022; 153 funds added in the latest 13F quarter.
ORDAN MARK S
Chief Executive Officer
SELL
2025-12-17 SECtraded 2025-12-15
23,000
$515.4K
+35.4%
Context
  • 4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Nov 13, 2024.
  • The trade is 7.6% of the 302,805 shares held after it.
  • 1 other insider sold within 30 days.
  • 153 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer ORDAN MARK S sold about $515.4K of MD on Dec 15, 2025, the largest insider sale at the company since 2022; 1 other insider sold within 30 days and 153 funds added in the latest 13F quarter.
Rucker Michael A.
Director
SELL
2025-11-19 SECtraded 2025-11-17
10,478
$241.0K
+28.8%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 17.7% of the 59,101 shares held after it.
  • 2 other insiders sold within 30 days.
  • 153 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Rucker Michael A. sold about $241.0K of MD on Nov 17, 2025, the largest insider sale at the company since 2024; 2 other insiders sold within 30 days and 153 funds added in the latest 13F quarter.
Linynsky Laura A
Director
SELL
2025-11-10 SECtraded 2025-11-06
10,000
$216.5K
+29.5%
Context
  • 1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Aug 27, 2024.
  • The trade is 31.0% of the 32,232 shares held after it.
  • 1 other insider sold within 30 days.
  • 153 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Linynsky Laura A sold about $216.5K of MD on Nov 6, 2025; 1 other insider sold within 30 days and 153 funds added in the latest 13F quarter.
ORDAN MARK S
Director
SELL
2024-11-14 SECtraded 2024-11-13
27,600
$423.7K
+107.0%
Context
  • 3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on May 25, 2023.
  • The trade is 19.9% of the 138,683 shares held after it.
  • 1 other insider sold within 30 days.
  • 153 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director ORDAN MARK S sold about $423.7K of MD on Nov 13, 2024, the largest insider sale at the company since 2023; 1 other insider sold within 30 days and 153 funds added in the latest 13F quarter.
37 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 32 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$855.7K over 180 days
more than 52% of Healthcare Services
Congress
no House purchase disclosed in the last 12 months
Funds
153 funds bought in last quarter
more than 60% of Healthcare Services
Revenue
-4.9% year over year
below 84% of Healthcare Services
Margin
8.6% net margin
more than 84% of Healthcare Services
Buybacks
$64.2M repurchased, FY to 2026-06-30
more than 58% of Healthcare Services
Short interest
5.9% of the float short (float per yahoo 2026-10-26) · 6.0 days to cover · settled 2026-09-30
more than 69% of Healthcare Services
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch MD

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+71.1%12M
-1%+24%+48%+73%2025-102025-122026-022026-042026-062026-082026-10 2026-05-13 · Weis Shirley A sold $855.7K2025-12-15 · ORDAN MARK S sold $515.4K2025-11-17 · Rucker Michael A. sold $241.0K2025-11-06 · Linynsky Laura A sold $216.5K2026-09-14 · Mary Ann E Moore filed to sell $246.4K2026-09-14 · Mary Ann E Moore filed to sell $572.6K2026-09-10 · Laura Linynsky filed to sell $160.7K2026-08-14 · Sylvia Young filed to sell $491.9K
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns MD: institutional holders (13F)

13F holdings, latest reported quarter
BlackRock, Inc.
13,714,275 sh
$347.4M
VANGUARD PORTFOLIO MANAGEMENT LLC
5,985,147 sh
$151.6M
DIMENSIONAL FUND ADVISORS LP
4,220,311 sh
$106.9M
VANGUARD CAPITAL MANAGEMENT LLC
3,620,040 sh
$91.7M
STATE STREET CORP
3,533,248 sh
$89.5M

Congress trades in MD

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

MD planned insider sales (Form 144)

Notice of intent to sell, filed before any sale
Mary Ann E Moore
Filed 2026-09-14
$246.4K
Mary Ann E Moore
Filed 2026-09-14
$572.6K
Laura Linynsky
Filed 2026-09-10
$160.7K
Sylvia Young
Filed 2026-08-14
$491.9K

MD mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
Rockefeller US Small Cap Core Fund
$2.9M position · as of 2026-05-31
2.9%
Nuveen Small Cap Value Opportunities Fund
$5.9M position · as of 2026-06-30
1.9%
Select Health Care Services Portfolio
$15.0M position · as of 2026-05-31
1.9%
Wasatch Small Cap Value Fund
$25.1M position · as of 2026-06-30
1.8%
State Street(R) SPDR(R) S&P(R) Health Care Services ETF
$2.4M position · as of 2026-06-30
1.7%
Allspring SMID Core ETF
$2.0M position · as of 2026-06-30
1.7%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $855.7K sold by insiders over 180 days, 153 funds added last quarter, $1.5M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
NTRACSTLPGNYHIMSWGSPRVATDOCAVAHGHADUSSERABDSX

MD financials

Revenue growth
-4.9%
XBRL, annual
Net margin
8.6%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$2.0B
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
+9.0%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
$228.6M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
0.45x
long-term debt only, 2026-06-30; equity 2026-06-30
Cash flow to debt
0.62x
TTM operating cash flow over long-term debt only, 2026-06-30
Return on equity
+20.4%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
+8.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
+16.7%
operating income after a 22.7% effective tax rate, over long-term debt only, 2026-06-30 plus average of 2025-06-30 and 2026-06-30 minus cash
Return on capital employed
+12.7%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
P/E, trailing
14.01x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
Enterprise value
$2.5B
market value at close 2026-10-23 on 2026-07-31 shares, plus long-term debt only, 2026-06-30, minus cash 2026-06-30
FCF yield
+9.6%
TTM free cash flow over market value at close 2026-10-23
PEG, trailing
0.23x
P/E over trailing EPS growth of 61%: four quarters to 2026-06-30 against the four to 2025-06-30
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$1.9B$2.0B$2.0B$2.0B
Operating income$208.8M-$68.7M$7.3M$172.7M
Net income$165.4M-$99.1M-$60.4M$66.3M
EPS (diluted)1.94-1.19-0.730.79
Operating cash flow$271.1M$206.6M$137.3M$166.9M
Cash$375.2M$229.9M$73.3M$9.8M
Long-term debt$570.5M$611.2M$622.2M$637.2M
Buybacks$86.7M$1.7M$919.0K$88.5M
SEC XBRL, fiscal years, as known on 2026-10-27

MD Stock Sonar score 6/7 axes

Find similar shapesCompare

MD ranks highest on profitability (79th percentile) and financial health (64th), and lowest on growth (16th), among Healthcare Services peers.

ProfitHealthGrowthInsidersInstitutionsRisk
Profitability
79
Inputs
  • Return on equity+20.4% · 83 pct, sector of 70
  • Return on assets+8.3% · 85 pct, sector of 88
  • Return on invested capital+16.7% · 66 pct, universe of 1,069
  • Return on capital employed+12.7% · 82 pct, sector of 68
Financial health
64
Inputs
  • Debt to equity0.45x · 48 pct, sector of 61
  • Cash flow to debt0.62x · 80 pct, sector of 66
Growth
16
Inputs
  • Revenue growth, YoY-4.9% · 16 pct, sector of 87
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
25
Inputs
  • Net Form 4 buying (codes P and S), 180d-$856K · 51 pct, sector of 64
  • Insider buyers, 180d0 · 0 pct, sector of 64
Institutional and government
61
Inputs
  • Funds adding, latest quarter153 · 60 pct, sector of 73
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quarters$688K · 63 pct, universe of 1,063
Risk and compliance
53
Inputs
  • Short interest, % of float+5.9% · 44 pct, sector of 95
  • Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
  • EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
  • New text in Risk Factors, latest 10-K+8.2% · 63 pct, sector of 72
1 not measured: US patents
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

MD filings, in plain words

Are Pediatrix Medical insiders buying or selling MD?

In the 180 days to 2026-10-27, Pediatrix Medical insiders were net sellers, a net $855.7K across purchases and sales reported on Form 4, by 1 seller.

Are there planned insider sales of MD?

Yes. 4 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $1.5M of stock; the latest, by Mary Ann E Moore, was filed 2026-09-14.

Read the full summary

In the 180 days to 2026-10-27, Pediatrix Medical insiders were net sellers of MD, a net $855.7K across purchases and sales reported on Form 4 by 1 seller. Insiders filed 4 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $1.5M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies